Jakafi Approved for Rare Bone-Marrow Disease
First drug in U.S. sanctioned for myelofibrosisContinue Reading
First drug in U.S. sanctioned for myelofibrosisContinue Reading
12-week intervals likely OK for those with stable doses of blood thinner, study findsContinue Reading
Study found it cut odds of death and heart attack, but bleeding risk needs monitoring, experts sayContinue Reading
Hospital patients with severe blood infections and new atrial fibrillation found at higher riskContinue Reading
Hemacord stem cell product sanctioned for certain blood cancers and related disordersContinue Reading
Researchers take steps toward noninvasive screening for fetal abnormalitiesContinue Reading
Medicine is safer for mini-stroke patients, as effective as new procedure, study findsContinue Reading
Atrial fibrillation affects more than 2 million AmericansContinue Reading
For some patients, using medicine to stave off, not just treat bleeds, could decrease joint damageContinue Reading
One-third of study patients over 60 had improved overall 5-year survival, researchers reportContinue Reading
But the likelihood is still small, researchers sayContinue Reading
Three gene types in heart patients and certain medications affected risk of dangerous clotsContinue Reading
Findings suggest clot-preventing measures should be considered in this patient group, researchers sayContinue Reading
A potential problem among people who get frequent blood transfusionsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.